194 related articles for article (PubMed ID: 19639181)
1. p53 is an important factor for the radiosensitization effect of 2-deoxy-D-glucose.
Sinthupibulyakit C; Grimes KR; Domann FE; Xu Y; Fang F; Ittarat W; St Clair DK; St Clair W
Int J Oncol; 2009 Sep; 35(3):609-15. PubMed ID: 19639181
[TBL] [Abstract][Full Text] [Related]
2. p53 Protects lung cancer cells against metabolic stress.
Sinthupibulyakit C; Ittarat W; St Clair WH; St Clair DK
Int J Oncol; 2010 Dec; 37(6):1575-81. PubMed ID: 21042727
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells.
Bandugula VR; N RP
Tumour Biol; 2013 Feb; 34(1):251-9. PubMed ID: 23065571
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.
Kriegs M; Gurtner K; Can Y; Brammer I; Rieckmann T; Oertel R; Wysocki M; Dorniok F; Gal A; Grob TJ; Laban S; Kasten-Pisula U; Petersen C; Baumann M; Krause M; Dikomey E
Radiother Oncol; 2015 Apr; 115(1):120-7. PubMed ID: 25796091
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of Non-Small Cell Lung Cancer Cells by Inhibition of TGF-β1 Signaling With SB431542 Is Dependent on p53 Status.
Zhao Y; Wang L; Huang Q; Jiang Y; Wang J; Zhang L; Tian Y; Yang H
Oncol Res; 2016; 24(1):1-7. PubMed ID: 27178816
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells.
Tang T; Fang D; Ji Z; Zhong Z; Zhou B; Ye L; Jiang L; Sun X
Cell Oncol (Dordr); 2024 Apr; 47(2):607-621. PubMed ID: 37867183
[TBL] [Abstract][Full Text] [Related]
7. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
8. BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways.
Leu JD; Lin ST; Chen CT; Chang CA; Lee YJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430560
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress.
Ahmad IM; Abdalla MY; Aykin-Burns N; Simons AL; Oberley LW; Domann FE; Spitz DR
Free Radic Biol Med; 2008 Mar; 44(5):826-34. PubMed ID: 18155176
[TBL] [Abstract][Full Text] [Related]
10. 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.
Coleman MC; Asbury CR; Daniels D; Du J; Aykin-Burns N; Smith BJ; Li L; Spitz DR; Cullen JJ
Free Radic Biol Med; 2008 Feb; 44(3):322-31. PubMed ID: 18215740
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of p53-deficient lung cancer cells by pre-treatment with cytostatic compounds.
Tokalov SV; Abolmaali N
Anticancer Res; 2012 Apr; 32(4):1239-43. PubMed ID: 22493354
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
14. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
15. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
Sottnik JL; Lori JC; Rose BJ; Thamm DH
Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
19. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.
Wang Y; Li N; Jiang W; Deng W; Ye R; Xu C; Qiao Y; Sharma A; Zhang M; Hung MC; Lin SH
Clin Cancer Res; 2018 Nov; 24(22):5744-5756. PubMed ID: 30068711
[No Abstract] [Full Text] [Related]
20. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
